Table 2 Comparative analysis of clinical data in two groups

duration on PD(month)

9(3-20.75)

16(6–28)

-2.731

0.006

WBC (10^9/L)

7.35 (6.01–9.23)

9.40 (6.65–12.05)

-3.349

0.001

NE (10^9/L)

5.61 (4.23–7.19)

7.70 (5.27–10.48)

-4.333

< 0.001

LY (10^9/L)

1.07 (0.80–1.30)

0.76 (0.50–1.08)

-4.406

< 0.001

PLT (10^9/L)

195.4 ± 65.32

234.61 ± 95.20

-3.184

0.002

SII

1034.66 (664.64-1522.02)

2379.06 (1235.78-3802.31)

-6.931

< 0.001

MLR

0.39 (0.28–0.54)

0.65 (0.40–0.90)

-4.669

< 0.001

NLR

5.55 (3.77–8.07)

10.43 (6.34–16.85)

-6.237

< 0.001

RBC (10^12/L)

3.21 (2.72–3.75)

3.28 (2.85-4.00)

-1.078

NS

HGB

96.67 ± 20.75

102.41 ± 24.87

-1.787

NS

PLR

185.06 (131.68–241.70)

303.64 (199.58-453.67)

-5.79

< 0.001

RDW (%)

13.70 (13.10–14.60)

13.80 (13.20–14.70)

-0.663

NS

CRP

56.35(16.18-108.98)

121.25(69.4-172.75)

-5.08

< 0.001

ALB (g/L)

32.51 ± 5.57

31.14 ± 6.91

1.467

NS

TC (mmol/L)

4.12 (3.48–5.02)

4.09 (3.46–5.23)

-0.167

NS

TG (mmol/L)

1.10 (0.83–1.58)

1.10 (0.78–1.65)

-0.266

NS

LDL (mmol/L)

2.37 (2.01–3.08)

2.22 (1.83–2.90)

-1.555

NS

HDL-C (mmol/L)

1.19 (0.9–1.48)

1.15 (0.88–1.45)

-0.807

NS

CRP/HDL-C

47.07 (13.83–103.20)

99.45 (65.61-155.95)

-4.938

< 0.001

Cr (umol/L)

825 (607.25-1052.25)

705 (500–931)

-2.714

0.007

BUN (mmol/L)

19.05 (15.4-25.24)

16.68 (12.55–22.49)

-1.958

0.05

UA (mmol/L)

343.5(299.5-404.25)

318(268–399)

-1.965

0.049

Calcium (mmol/L)

2.07 ± 0.23

2.09 ± 0.25

-0.581

NS

Phosphorus (mmol/L)

1.39 (1.13–1.66)

1.29 (1.09–1.52)

-1.524

NS

Magnesium (mmol/L)

0.83 (0.73–0.92)

0.77 (0.68–0.85)

-2.999

0.003

Potassium (mmol/L)

3.94 (3.60–4.62)

3.7 (3.22–4.21)

-2.678

0.007

Glucose (mmol/L)

6.09 (4.90–7.49)

5.88 (5.05–7.90)

-0.314

NS

dialysate leukocyte count (10^6/L)

1929 (674.50-6332.25)

2763 (947.50–5312)

-1.023

NS

dialysate polymorphonuclear cells

82.75 (65.60–90.10)

87.20 (79.75–93.50)

-2.91

0.004